ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
127 hedge funds and large institutions have $812M invested in Intra-Cellular Therapies Inc. in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 61 increasing their positions, 32 reducing their positions, and 23 closing their positions.
Holders
127
Holders Change
-5
Holders Change %
-3.79%
% of All Funds
3.39%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
19
Increased
61
Reduced
32
Closed
23
Calls
$5M
Puts
$10.4M
Net Calls
-$5.44M
Net Calls Change
+$5.27M
Top Buyers
| 1 |
EAM
1
EverPoint Asset Management
Stamford,
Connecticut
|
$18.1M |
| 2 |
O
2
OrbiMed
New York
|
$8.17M |
| 3 |
3
Millennium Management
New York
|
$34.3M |
| 4 |
TCM
4
TimesSquare Capital Management
New York
|
$42.4M |
| 5 |
5
Renaissance Technologies
New York
|
$6.5M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
151
Barclays
London,
United Kingdom
| $0 | 10 | +10 | New |
|